Cynthia Bean1, Shauna-Kay Spencer1, Teylor Bowles1, Patrick B Kyle2, Jan M Williams3, Jacob Gibbens1, Kedra Wallace4. 1. Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson, MS, USA. 2. Department of Pathology, University of Mississippi Medical Center, Jackson, MS, USA. 3. Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS, USA. 4. Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson, MS, USA. kwallace2@umc.edu.
Abstract
PROBLEM: Angiogenic imbalance during pregnancy is associated with immune activation, hypertension, increased T cell infiltration, and neurological insults. METHOD OF STUDY: On gestational day (GD) 12, timed-pregnant rats were infused with anti-angiogenic factors sFlt-1 and sEndoglin (4.7 and 7 μg/kg) to create HELLP syndrome via mini-osmotic pumps for 8 days, with a subset of these rats having Orencia (2 mg/kg) infused on GD13. On GD19, blood-brain barrier (BBB) permeability was evaluated via Evan's Blue infusion, blood was collected for T-cell measurements, inflammatory cytokine secretion. Brain tissues were also collected to examine inflammatory cytokine infiltration. RESULTS: T-cell attenuation with Orencia decreased circulating CD4(+) and CD8(+) T cells, circulating tumor necrosis factor alpha (TNFα) and IL-17, BBB permeability and significantly decreased biochemical evidence of HELLP compared to untreated HELLP rats. CONCLUSIONS: These data support the hypothesis that T cells have a critical role in contributing to the pathophysiology that is seen in angiogenic imbalance during pregnancy.
PROBLEM: Angiogenic imbalance during pregnancy is associated with immune activation, hypertension, increased T cell infiltration, and neurological insults. METHOD OF STUDY: On gestational day (GD) 12, timed-pregnant rats were infused with anti-angiogenic factors sFlt-1 and sEndoglin (4.7 and 7 μg/kg) to create HELLP syndrome via mini-osmotic pumps for 8 days, with a subset of these rats having Orencia (2 mg/kg) infused on GD13. On GD19, blood-brain barrier (BBB) permeability was evaluated via Evan's Blue infusion, blood was collected for T-cell measurements, inflammatory cytokine secretion. Brain tissues were also collected to examine inflammatory cytokine infiltration. RESULTS: T-cell attenuation with Orencia decreased circulating CD4(+) and CD8(+) T cells, circulating tumor necrosis factor alpha (TNFα) and IL-17, BBB permeability and significantly decreased biochemical evidence of HELLP compared to untreated HELLP rats. CONCLUSIONS: These data support the hypothesis that T cells have a critical role in contributing to the pathophysiology that is seen in angiogenic imbalance during pregnancy.
Authors: Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi Journal: Nat Med Date: 2006-06-04 Impact factor: 53.440
Authors: Gijs Kooij; Jack van Horssen; Elizabeth C M de Lange; Arie Reijerkerk; Susanne M A van der Pol; Bert van Het Hof; Joost Drexhage; Anke Vennegoor; Joep Killestein; George Scheffer; Ruud Oerlemans; Rik Scheper; Paul van der Valk; Christine D Dijkstra; Helga E de Vries Journal: J Autoimmun Date: 2009-12-02 Impact factor: 7.094
Authors: Lia E Taylor; Ellen E Gillis; Jacqueline B Musall; Babak Baban; Jennifer C Sullivan Journal: Am J Physiol Heart Circ Physiol Date: 2018-09-21 Impact factor: 4.733
Authors: Jamie Szczepanski; Shauna-Kay Spencer; Ashley Griffin; Teylor Bowles; Jan Michael Williams; Patrick B Kyle; John Polk Dumas; Sarah Araji; Kedra Wallace Journal: Biol Sex Differ Date: 2020-09-24 Impact factor: 5.027
Authors: Pablo R G Cardoso; Katherine A Matias; Andrea T Dantas; Claudia D L Marques; Michelly C Pereira; Angela L B P Duarte; Moacyr Jesus Barreto de Melo Rego; Ivan da Rocha Pitta; Maira Galdino da Rocha Pitta Journal: Open Rheumatol J Date: 2018-09-18